Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients

Annals of Neurology

Volumn 45, Issue 5, 1999, Pages 633-639

  Mayne, M ^a   Shepel, P N ^a   Jiang, Y ^a   Geiger, J D ^a   Power, C ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CYTOKINE; INTERLEUKIN 6; LIGAND; MESSENGER RNA; PHENYLISOPROPYLADENOSINE; PURINE RECEPTOR; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE; ADENOSINE RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOBLOTTING; LIGAND BINDING; MALE; MITOGENESIS; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PATHOGENESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; MONOCYTE;

ADENOSINE; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; RECEPTORS, PURINERGIC P1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032587884     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199905)45:5<633::AID-ANA12>3.0.CO;2-X     Document Type: Article

References (54)

1. Merrill JE. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 1992;12:167-170
2. Arvin B, Neville LF, Barone FC, Feuerstein GZ. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 1996;20:445-452
3. Ledeen RW, Chakraborty G. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis. Neurochem Res 1998;23:277-289
4. Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996;45:322-333
5. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503
6. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819
7. Martino G, Grohovaz F, Brambilla E, et al. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann Neurol 1998;43:340-349
8. Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78:318-323
9. Maimone D, Guazzi GC, Annunziata P. IL-6 detection in multiple sclerosis brain. J Neurol Sci 1997;146:59-65
10. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995;144:245-268
11. Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472
12. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994;76:5-13
13. Currin RT, Reinstein LJ, Lichtman SN, et al. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc 1993;25:1631-1632
14. Geiger JD, Parkinson FE, Kowaluk EA. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson JA, Jarvis MA, eds. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, 1997:55-84
15. Ciruela F, Saura C, Canela EI, et al. Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol Pharmacol 1997;52:788-797
16. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995;35:581-606
17. Bischofberger N, Jacobson KA, von Lubitz DK. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann NY Acad Sci 1997;825:23-29
18. Eigler A, Greten TF, Sinha B, et al. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol 1997;45:132-139
19. Hasko G, Szabo C, Nemeth ZH, et al. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996;157:4634-4640
20. McWhinney CD, Dudley MW, Bowlin TL, et al. Activation of adenosine A3 receptors in macrophages inhibits tumor necrosis factor-alpha. Eur J Pharmacol 1996;310:209-216
21. Sajjadi FG, Takabayashi K, Foster AC, et al. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 1996;156:3435-3442
22. Fiebich BL, Biber K, Gyufko K, et al. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 1996; 66:1426-1431
23. Schwaninger M, Neher M, Viegas E, et al. Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine. J Neurochem 1997;69:1145-1150
24. Cronstein BN. The antiheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism. Br J Rheumatol 1995;34:30-32
25. Mayne M, Krishnan J, Metz L, et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol 1998;44:391-394
26. Power C, McArthur JC, Johnson RT, et al. Distinct HIV-1 end sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol 1995;202:89-104
27. Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV-1 associated neurological diseases. J Biol Chem 1997;272:22385-22388
28. Linden J, Taylor HE, Feldman MD, et al. The precise radioimmunoassay of adenosine: minimization of sample collection artifacts and immunocrossreactivity. Anal Biochem 1992;201: 246-254
29. Zhang Y, Geiger JD, Lautt WW. Improved high-pressure liquid chromatographic-fluorometric assay for measurement of adenosine in plasma. Am J Physiol 1991;260(Suppl):G658-G664
30. Gough N. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 1988;173: 93-95
31. Sommer N, Loschmann PA, Northoff GH, et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1995;1:244-248
32. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-582
33. Franco R, Casado V, Ciruela F, et al. The cluster-arranged co-operative model: a model that accounts for the kinetics of binding to A1 adenosine receptors. Biochemistry 1996;35:3007-3015
34. Saura CA, Mallol J, Canela EI, et al. Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 1998;273: 17610-17617
35. Ciruela F, Casado V, Mallol J, et al. Immunological identification of A1 adenosine receptors in brain cortex. J Neurosci Res 1995;42:818-828
36. Cronstein BN. A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites. Journal of Investigational Medicine 1995;43:50-57
37. Le Moine O, Stordeur P, Schandene L, et al. Adenosine enhances IL-10 secretion by human monocytes. J Immunol 1996; 156:4408-4014
38. Le Vraux V, Chen YL, Masson I, et al. Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 1993;52:1917-1924
39. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994;153:4159-4168
40. Schubert P, Ogata T, Marchini C, et al. Protective mechanisms of adenosine in neurons and glial cells. Ann N Y Acad Sci 1997;825:1-10
41. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-954
42. Spuler S, Yousry T, Scheller A, et al. Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 1996;66:57-64
43. Selmaj K, Raine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694-700
44. Selmaj K, Papierz W, Glabinski A, Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 1995;56:135-141
45. Okuda Y, Sakoda S, Fujimura H, Yanagihara T. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. Immunopharmacology 1996;35:141-148
46. Probert L, Akassoglou K, Pasparakis M, et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A 1995;92:11294-11298
47. Frei K, Eugster HP, Bopst M, et al. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997;185:2177-2182
48. Martino G, Consiglio A, Franciotta DM, et al. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. J Neurol Sci 1997;152:51-61
49. Diab A, Zhu J, Xiao BG, et al. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J Neuropathol Exp Neurol 1997;56:641-650
50. Hermans G, Stinissen P, Hauben L, et al. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann Neurol 1997;42:18-27
51. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 1994;153:3811-3821
52. Imamura K, Suzumura A, Hayashi F, Marunouchi T. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 1993;87:281-285
53. Rieckmann P, Albrecht M, Ehrenreich H, et al. Semiquantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl) 1995;195:17-29
54. Rieckmann P, Albrecht M, Kitze B, et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994;44:1523-1526